Grant: IMMUNE DISEASE INSTITUTE, INC.
Primary Recipient
IMMUNE DISEASE INSTITUTE, INC.
Amount
$995,573.00
Award Date
9/29/2009
Administering Agency
Health and Human Services, Department of / National Institutes of Health
CDFA Number
93.701
CDFA Program Title
Trans-NIH Recovery Act Research Support
Description
Dysregulation of the immune system, which induces an aberrant activation of leukocytes, plays a critical role in the pathogenesis of a wide range of autoimmune and immunological disorders including such inflammatory bowel diseases (IBD) as ulcerativecolit
Recipients Connected to Award
Recipient | Role | Amount |
---|---|---|
IMMUNE DISEASE INSTITUTE, INC. | Primary recipient | $719,523.00 |
CHILDREN'S HOSPITAL CORPORATION, THE | Sub-recipient | $170,102.00 |
BETH ISRAEL DEACONESS MEDICAL CENTER INC | Sub-recipient | $80,282.00 |
TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | Sub-recipient | $25,666.00 |